Fundraising FoxZAKA VC — 2026 Investments
2 investments dated 2026 · listed companies and verified rows first · show all
ParcelBio develops APEXm, a proprietary mRNA platform that enhances protein expression for longer-lasting therapeutic effect compared to conventional mRNA technologies.
AI & Machine LearningBiotechDeep TechHealthtechSan Francisco, US
David Weinberg(CEO)inChris Carlson(Founder)in
BoardMorgan Cheatham(Director)in
Co-investorsY CombinatorBreyer CapitalGeneral CatalystAlumni VenturesLexi VenturesMetaplanet+12 more
.png)
Sygaldry develops quantum-accelerated AI servers that combine multiple qubit modalities to speed up training and inference for AI models.
Advanced ManufacturingAI & Machine LearningHardwareQuantum ComputingAnn Arbor, US
Chad Rigetti(CEO)inIdalia Friedson(Founder)inMeghan Hudson(Head of HR)
BoardChristian Garcia(Director)inAndrew Sather(Director)inMichael Keiser(Founder)in
Co-investorsAlumni VenturesBloomberg BetaCollaborative FundDetroit Venture PartnersEarth Venture CapitalEight Capital+51 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.